Showing results (951-960 of 966) with videos related to
Sort By:
Pageof 97
Biochemical and Biophysical Research Communications|September 4, 1996
Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivoH Obayashi, K Nakano, H Shigeta, et al.Psycho-Oncology|February 1, 2019
Use of antidepressants after colon cancer diagnosis and risk of recurrenceGaia Pocobelli, Onchee Yu, Rebecca A Ziebell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 26, 2015
Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)K Tanabe, M Fujii, K Nishikawa, et al.JAMA Network Open|July 25, 2024
Reducing Central Nervous System-Active Medications to Prevent Falls and Injuries Among Older Adults: A Cluster Randomized Clinical TrialElizabeth A Phelan, Brian D Williamson, Benjamin H Balderson, et al.The Journal of Biological Chemistry|October 23, 1997
Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cellsK Akita, T Ohtsuki, Y Nukada, et al.Journal of the American College of Cardiology|November 3, 2001
Relationship between plasma level of cardiotrophin-1 and left ventricular mass index in patients with dilated cardiomyopathyT Tsutamoto, A Wada, K Maeda, et al.Cancer Causes & Control : CCC|November 1, 2019
Changes in use of opioid therapy after colon cancer diagnosis: a population-based studyLu Chen, Jessica Chubak, Onchee Yu, et al.Cancer Causes & Control : CCC|September 24, 2018
Risk of colon cancer recurrence in relation to diabetesJessica Chubak, Onchee Yu, Rebecca A Ziebell, et al.ESMO Open|May 7, 2025
Genome-wide DNA methylation status as a biomarker for clinical outcomes of first-line treatment in patients with RAS wild-type metastatic colorectal cancer: JACCRO CC-13ARK Ouchi, Y Sunakawa, A Tsuji, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2017
A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD GroupH Bleiberg, G Decoster, A de Gramont, et al.Pageof 97